Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia

Anxiety Clinical Trial

— VR OP- tour  

Official title:

Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia in an Operating Setting: A Randomized Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04579354
• Other study ID #: EK037/20
• Secondary ID: CTC-A 20-026
• Status: Completed
• Phase: N/A
• Start date: September 7, 2020
• Est. completion date: January 1, 2021

Study information

• Verified date: March 2021
• Source: RWTH Aachen University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Anxiety and apprehension are common among patients prior to surgery. This anxiety can lead to additional discomfort, increased pain sensation and increased stress symptoms. Virtual exposure has proven to be successful in exposure therapy for the treatment of the narrowest patients. Patients are not confronted with the real stimuli or situations that trigger the branches, but with virtual representations of them. Virtual reality (VR) makes it possible to create scenarios that would not be possible in reality because of the organisational, time or financial expenditure involved.The effectiveness of virtual stimulus exposure is well documented, especially in the case of object or situation-related fears in the context of specific phobias. It is therefore obvious that virtual stimulus exposure could also be suitable for minimising operation-associated fears.The research project described is designed to investigate the effect of virtual stimulus exposure on perioperative anxiety. For this purpose, a virtual tour of the operating setting has been created, which enables patients to explore the surroundings in detail by means of VR glasses.

Description:

Anxiety and apprehension are common among patients prior to surgery. This anxiety can lead to additional discomfort, increased pain sensation and increased stress symptoms. Virtual exposure has proven to be successful in exposure therapy for the treatment of the narrowest patients. Patients are not confronted with the real stimuli or situations that trigger the branches, but with virtual representations of them. Virtual reality (VR) makes it possible to create scenarios that would not be possible in reality because of the organisational, time or financial expenditure involved.The effectiveness of virtual stimulus exposure is well documented, especially in the case of object or situation-related fears in the context of specific phobias. It is therefore obvious that virtual stimulus exposure could also be suitable for minimising operation-associated fears.The research project described is designed to investigate the effect of virtual stimulus exposure on perioperative anxiety. For this purpose, a virtual tour of the operating setting has been created, which enables patients to explore the surroundings in detail by means of VR glasses.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 84
• Est. completion date: January 1, 2021
• Est. primary completion date: October 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• all patient undergoing anaesthesia without the following exclusion criteria

Exclusion Criteria:

• < 18 years
• cancer surgery
• pregnancy
• postoperative setting ICU
• neurosurgery
• Thorax surgery

Related Conditions & MeSH terms

• Anaesthesia
• Anxiety
• Anxiety Disorders
• Postoperative Pain

Intervention

Other:
• virtual reality tour
Patients will be guided via VR on their way through the hospital to the operating theater

Locations

Country	Name	City	State
Germany	RWTH Aachen University	Aachen	NRW

Sponsors (1)

Lead Sponsor	Collaborator
RWTH Aachen University

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	STOA State T1	Questinaire STOA State T1 before anaesthesia	before anaesthesia
Secondary	STOA State T2	Questionaire STOA State T2 after anaesthesia	within 48 hours after anaesthesia